Descriptive data of 232 children treated for ROP during 2007–2014 and registered in the Swedish national quality register for ROP
Sex | N (%) | |
Girl | 92 (39.48) | |
Boy | 140 (60.32) | |
Age at examination (year) | Mean (SD) | 6.57 |
Median | 6.5 | |
Range | 2.8–12.3 | |
GA at birth (week) | Mean (SD) | 24.97 (1.63) |
Median | 24.71 | |
Range | 22.0–30.14 | |
BW (gram) | Mean (SD) | 699 (175) |
Median | 668 | |
Range | 400–1230 | |
BWSDS | Mean (SD) | −0.34 (0.85) |
Median | −0.25 | |
Range | -2.6-1.4 | |
BPD | N (%) | |
Yes | 159 (68.53) | |
No | 73 (31.47) | |
NEC | N (%) | |
Yes | 44 (18.97) | |
No | 188 (81.03) | |
Brain lesion | N (%) | |
Yes | 32 (13.79) | |
No | 200 (86.21) | |
Maximum no of treatments | Mean (SD) | 1.44 (0.74) |
Median | 1 | |
Range | 1-5 | |
PNA at first treatment | Mean (SD) | 12.87 (2.90) |
Median | 12.43 | |
Range | 7.0–25.57 | |
PMA at first treatment | Mean (SD) | 37.85 (3.13) |
Median | 37.14 | |
Range | 32.43–52.14 |
Brain lesion defined as intraventricular hemorrhage ≥3 and/or periventricular leukomalacia.
BPD, bronchopulmonary disease; BW, birth wt; BWSDS, birth weight SD score; GA, gestational age; NEC, necrotising enterocolitis; n, number; PMA, postmenstrual age; PNA, postnatal age; ROP, retinopathy of prematurity.